Kyrou Ioannis, Adesanya Olu, Hedley Nicholas, Wayte Sarah, Grammatopoulos Dimitris, Thomas Claire L, Weedall Andrew, Sivaraman Subash, Pelluri Lavanya, Barber Thomas M, Menon Vinod, Randeva Harpal S, Tedla Miroslav, Weickert Martin O
Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham, United Kingdom.
Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
Front Endocrinol (Lausanne). 2018 Aug 24;9:488. doi: 10.3389/fendo.2018.00488. eCollection 2018.
Obesity may affect both biochemical thyroid function tests; and thyroid morphology, as assessed using ultrasound scans (US). The aim of the present pilot study was to explore whether weight loss achieved by bariatric surgery alters thyroid US morphology including gray-scale measurements; and/or function in euthyroid adults with severe obesity. Euthyroid adults (>18 years) with body mass index (BMI) ≥40 kg/m and negative thyroid peroxidase antibodies were assessed at baseline (pre-surgery) and after achieving at least 5% weight loss of their baseline body weight following bariatric surgery. Anthropometric assessments, biochemical/hormonal measurements (TSH, free-T4, free-T3, reverse-T3, and leptin) and thyroid US with gray-scale histogram analysis were performed at the baseline and post-surgery follow-up. Ten Caucasian, euthyroid patients (women/men: 8/2; age: 48.6 ± 3.1 years; BMI: 51.4 ± 1.8 kg/m) successfully completed this study with significantly decreased body weight (>5% weight loss), waist circumference and serum leptin levels post-surgery (mean post-surgery follow-up duration: 16.5 ± 2.5 months). In parallel to the observed bariatric-induced weight loss, thyroid US echogenicity increased by 25% ( = 0.03), without significant changes in thyroid volume. No significant changes in thyroid function tests were detected. No significant correlations were observed between the increase in thyroid echogenicity and the decreases in anthropometric parameters and circulating leptin. Our results indicate that in euthyroid adults with severe obesity, marked weight loss achieved by bariatric surgery is associated with a parallel significant increase in the thyroid US echogenicity, suggesting that morphological changes of the thyroid in obesity are reversible with weight loss. : www.ClinicalTrials.gov, identifier: NCT03048708.
肥胖可能会影响甲状腺功能生化检测以及甲状腺形态(通过超声扫描[US]评估)。本初步研究的目的是探讨减肥手术实现的体重减轻是否会改变甲状腺超声形态(包括灰阶测量)和/或重度肥胖的甲状腺功能正常成年人的甲状腺功能。对体重指数(BMI)≥40 kg/m²且甲状腺过氧化物酶抗体阴性的甲状腺功能正常成年人(>18岁)在基线时(术前)以及减肥手术后体重至少减轻其基线体重的5%后进行评估。在基线和术后随访时进行人体测量评估、生化/激素测量(促甲状腺激素、游离T4、游离T3、反T3和瘦素)以及带有灰阶直方图分析的甲状腺超声检查。10名白种人甲状腺功能正常患者(女性/男性:8/2;年龄:48.6±3.1岁;BMI:51.4±1.8 kg/m²)成功完成了本研究,术后体重、腰围和血清瘦素水平显著降低(术后平均随访时间:16.5±2.5个月)。与观察到的减肥手术引起的体重减轻同时,甲状腺超声回声增强了25%(P = 0.03),甲状腺体积无显著变化。未检测到甲状腺功能测试有显著变化。甲状腺回声增强的增加与人体测量参数和循环瘦素的降低之间未观察到显著相关性。我们的结果表明,在重度肥胖的甲状腺功能正常成年人中,减肥手术实现的显著体重减轻与甲状腺超声回声显著平行增加相关,提示肥胖时甲状腺的形态变化可随体重减轻而逆转。试验注册网址:www.ClinicalTrials.gov,标识符:NCT03048708。